TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TYRA

Tyra Biosciences Inc

Healthcare · Biotechnology

21.80$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Tyra Biosciences Inc (TYRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 383 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TYRA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
238 226 405 392 381 364 343 321 302 283 412 383
225 212 391 379 366 347 325 302 281 265 395 367
216 58 254 99 104 92 101 98 62 77 85 74
216 203 382 374 360 341 319 296 275 256 383 354
– 0.7 1.5 1.9 1.9 2.0 1.8 1.7 2.2 – – –
16 22 15 16 18 20 20 19 21 23 24 30
10 15 8.7 10 12 15 14 14 16 18 19 25
0.1 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5
2.3 4.7 2.9 1.6 1.2 0.6 2.5 2.2 2.0 1.2 3.6 2.3
222 204 390 376 362 343 324 302 281 259 388 354
-142 -165 -183 -202 -226 -251 -279 -308 -337 -371 -411 -456
43 43 52 59 59 59 59 60 60 60 62 66

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?